Navigation Links
Bionomics Achieves US$1 Million Milestone Payment from Genmab
Date:2/19/2008

s for cancer to the clinic."

The CEO of Genmab Lisa N Drakeman, PhD commented: "We are pleased to reach the next level of development with these targets and look forward to continuing the collaboration with Bionomics."

Professor Jan G J van de Winkel, PhD, Chief Scientific Officer of Genmab added: "This milestone has been reached following extensive studies by Genmab on the Bionomics targets. The work we have undertaken has confirmed and extended the work performed by Bionomics, further supporting their potential as new targets for therapeutic antibodies."

Bionomics has the rights and is actively developing a large number of additional proprietary proteins discovered through its angiogenesis program, including BNO69. In addition Bionomics' anti-cancer drug BNC105 will soon commence a Phase 1 clinical trial at the Peter MacCallum Cancer Centre, Royal Melbourne Hospital and Western Hospital cancer centres in Melbourne for the treatment of solid tumours including breast, colon and prostate cancers. BNC105 was identified using the Angene(R) platform. Bionomics' Investigational New Drug (IND) submission for BNC105 was accepted by the US Food and Drug Administration in November 2007.

About Bionomics Limited:

Bionomics (ASX: BNO) discovers and develops innovative therapeutics for cancer and diseases of the central nervous system. Bionomics has small molecule product development programs in the areas of cancer, anxiety, epilepsy and multiple sclerosis. Bionomics' discovery and development activities are driven by its three technology platforms: Angene(R), the company's angiogenesis target and drug discovery platform, incorporates a variety of genomics tools to identify and validate novel angiogenesis targets. MultiCore(R) is Bionomics' proprietary, diversity orientated chemistry platform for the discovery of small molecule drugs. ionX(R) is a set of novel technologies for the identification of drugs targeting ion channels for diseases of t
'/>"/>

SOURCE Bionomics Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
2. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
3. Surface Logix Achieves Objectives With SLx-2101 in Phase 2a Clinical Trial in Hypertension
4. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
5. PLC Systems Achieves Successful Early Conclusion of RenalGuard(TM) Pilot Safety Trial
6. Cethromycin Achieves All Endpoints in Second Pivotal Phase III Trial for Treatment of Pneumonia
7. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
8. Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy
9. BioVascular Inc. Closes $10.87 Million Series C Financing
10. Joslin Study Identifies Key Factor That Links Metabolic Syndrome; Finding May Help Millions at High Risk of Cardiovascular Disease
11. Michael J. Fox Foundation Awards Up to $3 Million to Industry Teams to Jumpstart Promising PD Drug Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... March 27, 2015  Holographic Optical Technologies of ... of holographic medical imaging, is entering the world of ... Launching on April 20 th , 2015, the campaign ... The 8-inch and 22-inch displays will allow consumers to ... first time. In addition to the two displays, the ...
(Date:3/27/2015)... -- A new report from Kalorama Information says that other ... Chile , Colombia and ... firms.  The healthcare research firm said that while ... Latin American continent with a population of over 200 million ... the country,s regional economic clout does not necessarily ensure its ...
(Date:3/27/2015)... Report Details  New study shows ... What does the future hold for top companies ... new report shows you potential revenues to 2025, assessing ... 242-page report provides 185 tables, charts, and graphs. Discover ... future market prospects. Our new study lets you assess ...
Breaking Medicine Technology:Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7
... and author on geriatrics and medical issues related ... Alzheimer,s Study Group (ASG), a new national,task force ... Gingrich and,former U.S. Senator Bob Kerrey., Dr. ... the American,Board of Internal Medicine (http://www.abim.org ), ...
... Worldwide Awareness and Funds ... Fight Aids, Tuberculosis and Malaria, SEATTLE, Nov. 28 ... distributor, today announced,the successful conclusion of "Change Me," an initiative ... thoughts on how to make the,world a better place. The ...
Cached Medicine Technology:American Board of Internal Medicine President Named to Alzheimer's Study Group 2Getty Images Celebrates Conclusion of 'Change Me' Imagery Forum 2Getty Images Celebrates Conclusion of 'Change Me' Imagery Forum 3
(Date:3/30/2015)... Mo. (PRWEB) March 30, 2015 ... a mobile library of medications used in behavioral ... for iPhone, iPad and Android—is a convenient, electronic ... annually since 1999. The useful resource provides up-to-date ... purpose, dosage and frequency, side effects, emergency conditions, ...
(Date:3/30/2015)... 2015 BioFit Engineered ... manufacturer of ergonomic seating solutions, now offers ... new upholsteries bolster the company’s existing selection ... providing disinfectable, green choices. , The BioFit ... purveyor CF Stinson. Six disinfectable patterns consisting ...
(Date:3/29/2015)... Cokato, MN (PRWEB) March 30, 2015 ... (IHRSA) Show, Helo Commercial introduced the new ... through AEC Daily. , Club owners and facilities ... 7’x8’x7’) like the new, sleek design of the Fonda ... the heater, the heater is an immediate upgrade for ...
(Date:3/29/2015)... (PRWEB) March 29, 2015 Women’s ... menopause treatment. Secondary to their location in Birmingham, ... hospital option. They continue to be affiliated with ... , Menopause is a normal condition that all ... describe any of the changes a woman goes through ...
(Date:3/29/2015)... The culmination of one of the most exciting sporting events ... invades Lucas Oil Stadium in Indianapolis IN. The 2015 ... buzzer-beaters, and of course, upsets. Throughout the dozens of games ... future professional products have been seen. In the end, it ... advanced through their regional bracket with the hopes of winning ...
Breaking Medicine News(10 mins):Health News:Popular Publication on Behavioral Health Medications Now An App 2Health News:BioFit Adds Bleachable Upholstery Options to Seating Line 2Health News:Helo Commercial Introduces Fonda Sauna Heater and Sauna and Steam Continuing Education Program at IHRSA 2Health News:Women's Excellence Affiliates with Beaumont Hospital, Treats Menopause 2Health News:Cheap 2015 Final Four Tickets: Ticket Down Slashes Kentucky Wildcats and Wisconsin Badgers Final Four Tickets at Lucas Oil Stadium and Issues Valuable Promo Code 2
... European Respiratory Society (ERS) and the European Centre for ... European Union Standards for Tuberculosis Care (ESTC). The 21 ... workers to ensure optimal diagnosis, treatment and prevention of ... TB cases in the EU/EEA in 2010 clearly showing ...
... cancer had limited side effects and in many cases ... a small-molecule oral drug, according to phase I data ... March 31 - April 4. Castration-resistant prostate cancer ... occurs when the disease progresses after treatment with androgen ...
... By Steven Reinberg HealthDay Reporter , FRIDAY, March ... two hours more in labor during childbirth than women did ... authors said several factors helped to explain the longer labors. ... ratio of weight to height) accounted for a part of ...
... FRIDAY, March 30 (HealthDay News) -- People who have ... more likely to use hospital emergency departments, a new ... is an important indicator of access to care. People ... emergency departments for medical care, said Dr. Adit Ginde, ...
... than did women 50 years ago, according to an analysis ... Institutes of Health. The researchers could not identify all of ... the change is likely due to changes in delivery room ... determine whether modern delivery practices are contributing to the increase ...
... March 30 (HealthDay News) -- The declining number of ... is cause for concern because there,s already a shortage ... has occurred for the past six years, according to ... need to provide more information and training to medical ...
Cached Medicine News:Health News:Towards TB elimination: ECDC and ERS introduce new guidelines on tuberculosis care in Europe 2Health News:Early clinical data show galeterone safe, effective against prostate cancer 2Health News:U.S. Women in Labor Longer Than They Were 50 Years Ago 2Health News:Changes in Insurance Make ER Visits More Likely: Study 2Health News:NIH study finds women spend longer in labor now than 50 years ago 2Health News:NIH study finds women spend longer in labor now than 50 years ago 3Health News:Fewer U.S. Med Students Choose Psychiatry: Report 2
Angled, 7.5 mm tying platforms.,Titanium, 111 mm long, 6 mm tying platforms....
Gills Colibri forceps, very fine pointed tips....
Castroviejo tying forceps, tying platforms, straight, 0.3 mm teeth....
Microsurgical straight forceps made of titanium has straight shafts with smooth working surface. TCI working parts 6 mm from tips with round handle, diam. 6 mm, overall length 116 mm....
Medicine Products: